Very interesting but there's been such low volume considering "the news" I don't expect it this week but maybe in the coming weeks.
No educated shareholder sold IMO.
But they may as the price rises to 1/share just happy to get out.
That's the game and I'll be holding strong and watching.
Like I said the Bavituximab arm was trending as designed for sunrise this in itself is huge news. Bavituximab has a tail to its mos, patients literally may live greater then 20 months or more and since sunrise is active and now "open-label study" mos will be scene in realtime.
Dr. Birges article gives me great confidence in my investment.
Market Data 
Markets 
AI
